Prospective Randomized Group Controlled Multicenter Study of Clinical Efficacy and Safety of VH90D

Prospective Randomized Group Controlled Multicenter Study of Clinical Efficacy and Safety of VH90D - RCT VH-90-D multi

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00028026

Enrollment

220

Registered

2023-12-12

Start date

2022-10-10

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H81

Interventions

Group 1: During 12 weeks: BEV (adaptive Balance movements, Eye-movements and Visual stimulation exercises), (ii) health education (HE) and (iii) CBT (cognitive behavioral therapy), (iv) MC: Medical Co

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: vestibular vertigo

Exclusion criteria

Exclusion criteria: Severe bone disease Severe internal disease Severe neurological disease Central vertigo Severe visual disorder No German language

Design outcomes

Primary

Measure	Time frame
VSS-V-Scale. VSS-sf-VER-questionaire at T0, after 2, 6 and 12 weeks.	—

Secondary

Measure	Time frame
DHI, CGI-I, CGI-S, Stress thermometer, VSS-sf-AA, SF 36	—

Countries

Germany

Contacts

Public ContactUlrike Heller

Facharztpraxis

office@hpzenner.de+497071049645

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026